Mycotoxins: Mechanisms of action at the molecular level

被引:0
作者
Fink-Gremmels, J [1 ]
机构
[1] Dept Vet Basic Sci, Div Pharmacol & Toxicol, NL-3508 TD Utrecht, Netherlands
来源
MYCOTOXINS AND PHYCOTOXINS - DEVELOPMENTS IN CHEMISTRY, TOXICOLOGY AND FOOD SAFETY | 1998年
关键词
aflatoxin; ochratoxin; fumonisin; genotoxicity; carcinogenicity; biotransformation;
D O I
暂无
中图分类号
S3 [农学(农艺学)];
学科分类号
0901 ;
摘要
Mycotoxins comprise a group of chemically diverse compounds exerting a broad variety of biochemical effects.. In the evaluation of the possible role of mycotoxins in human diseases, molecular mechanisms involved in chemically induced carcinogenesis are of particular interest. Metabolism mediated toxicity was first described for aflatoxin B1 and the species-specific balance between CYP450-dependent activation and the further processing of the electrophilic metabolites have been used to correlate experimental data to epidemiological investigations. Recent technologies in molecular biology allow the detailed description of human isoenzymes involved in biotransformation processes and also the characterization of the mutations initiating tumour development. A parallel approach has been applied to identify the role of biotransformation processes in the etiology of ochratoxin A related pathologies. As ochratoxin A is a typical nephrotoxin, renal-specific biotransformation processes seem to be involved in the target organ toxicity. In contrast to aflatoxin B1 and ochratoxin A, fumonisins exert their toxicity by a completely different mechanism. Fumonisin B1 has been found to disrupt sphingolipid biosynthesis both in vivo and in vitro, resulting in an accumulation of free sphinganine. This effect has been observed in all target tissues including liver, kidneys and the central nervous system and is considered to be the primary event in the species-specific pathologies related to dietary fumonisin exposure. Furthermore, there is accumulating evidence that this mechanism is involved in the tumour promoting activity of fumonisins as well. These findings imply, that fumonisins exert not only a unique effect in relation to other mutagenic and carcinogenic mycotoxins but also in comparison to other neurotoxic mycotoxins.
引用
收藏
页码:247 / 262
页数:16
相关论文
共 72 条
[1]   AFLATOXIN-B(1) INDUCES THE TRANSVERSION OF G-]T IN CODON 249 OF THE P53 TUMOR-SUPPRESSOR GENE IN HUMAN HEPATOCYTES [J].
AGUILAR, F ;
HUSSAIN, SP ;
CERUTTI, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (18) :8586-8590
[2]   RELEVANCE OF A RAT MODEL OF PAPILLARY NECROSIS AND UPPER UROTHELIAL CARCINOMA IN UNDERSTANDING THE ROLE OF OCHRATOXIN A IN BALKAN ENDEMIC NEPHROPATHY AND ITS ASSOCIATED CARCINOMA [J].
BACH, PH ;
GREGG, NJ ;
DELACRUZ, L .
FOOD AND CHEMICAL TOXICOLOGY, 1992, 30 (03) :205-211
[3]   EVALUATION OF OCHRATOXIN-A FOR MUTAGENICITY IN A BATTERY OF BACTERIAL AND MAMMALIAN-CELL ASSAYS [J].
BENDELE, AM ;
NEAL, SB ;
OBERLY, TJ ;
THOMPSON, CZ ;
BEWSEY, BJ ;
HILL, LE ;
REXROAT, MA ;
CARLTON, WW ;
PROBST, GS .
FOOD AND CHEMICAL TOXICOLOGY, 1985, 23 (10) :911-918
[4]   STRUCTURE ELUCIDATION OF THE FUMONISINS, MYCOTOXINS FROM FUSARIUM-MONILIFORME [J].
BEZUIDENHOUT, SC ;
GELDERBLOM, WCA ;
GORSTALLMAN, CP ;
HORAK, RM ;
MARASAS, WFO ;
SPITELLER, G ;
VLEGGAAR, R .
JOURNAL OF THE CHEMICAL SOCIETY-CHEMICAL COMMUNICATIONS, 1988, (11) :743-745
[5]  
Boorman G.A, 1989, NIH PUBLICATION
[6]  
Buetler TM, 1996, CANCER RES, V56, P2306
[7]   CANCER PROGRESSION AND P53 [J].
CARSON, DA ;
LOIS, A .
LANCET, 1995, 346 (8981) :1009-1011
[8]  
CASTEGNARO M, 1987, CANCER RES, V47, P3608
[9]  
CERUTTI P, 1994, CANCER RES, V54, pS1934
[10]   ALTERATIONS IN ATP-DEPENDENT CALCIUM-UPTAKE BY RAT RENAL-CORTEX MICROSOMES FOLLOWING OCHRATOXIN A ADMINISTRATION INVIVO OR ADDITION INVITRO [J].
CHONG, X ;
RAHIMTULA, AD .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (07) :1401-1409